• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

透明细胞肾细胞癌中E47样因子的综合分析及ELF4的验证

Comprehensive analysis of E47‑like factors and verification of ELF4 in clear cell renal cell carcinoma.

作者信息

Lu Jun, Zhang Qianqian, Mo Licai, Chen Weiying, Mao Linghong

机构信息

Department of Urology, Taizhou Hospital of Zhejiang Province Affiliated to Wenzhou Medical University, Taizhou, Zhejiang 310000, P.R. China.

Department of Urology, Enze Hospital, Taizhou Enze Medical Center, Taizhou, Zhejiang 310000, P.R. China.

出版信息

Oncol Lett. 2023 Jul 27;26(3):395. doi: 10.3892/ol.2023.13981. eCollection 2023 Sep.

DOI:10.3892/ol.2023.13981
PMID:37600328
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10433703/
Abstract

Clear cell renal cell carcinoma (ccRCC) is the most prominent subtype of renal cancer and E47-like factors (ELFs) are important in tumorigenesis; however, the specific role of key ELFs in ccRCC remains unclear. The present study comprehensively analyzed RNA sequencing and clinical data from multiple databases, and identified differentially expressed ELFs (ELF3-5) in ccRCC. The DNA promoter methylation, genetic variation and clinical significance of ELF3-5 in ccRCC were analyzed using the cBioPortal and UALCAN databases. The association between ELF3-5 and multiple immune cell infiltration was analyzed using Tumor Immune Estimation Resource. Subsequently, ELF4 was selected and its association with biological functions was assessed. Cell counting kit-8 (CCK-8), colony formation, Transwell, macrophage chemotaxis and polarization assays were conducted to validate the functions of ELF4. Notably, the mRNA expression levels of ELF4 were significantly upregulated in ccRCC, whereas ELF3 and ELF5 mRNA expression levels were significantly downregulated. Clinical significance analysis revealed that ELF4 showed a high clinical significance with tumor grade, clear cell type A and B subtypes, and incidence rates of amplification in genetic variation. Further analyses indicated that ELF4 may be involved in multiple immune cell differentiation. Additionally, cell experiments revealed that ELF4 inhibition downregulated 769-P and 786-O proliferation, migration and invasion. Knockdown of ELF4 in cancer cells also inhibited M2 macrophage polarization and chemotaxis towards 769-P and 786-O cells. Conclusively, the present findings indicated the clinical significance of ELF4 in ccRCC, and verified its key role in driving cell proliferation, migration and invasion, and promoting M2 macrophage polarization and chemotaxis in ccRCC.

摘要

透明细胞肾细胞癌(ccRCC)是肾癌最主要的亚型,E47样因子(ELFs)在肿瘤发生中起重要作用;然而,关键ELFs在ccRCC中的具体作用仍不清楚。本研究综合分析了多个数据库的RNA测序和临床数据,鉴定出ccRCC中差异表达的ELFs(ELF3 - 5)。使用cBioPortal和UALCAN数据库分析了ELF3 - 5在ccRCC中的DNA启动子甲基化、基因变异及临床意义。使用肿瘤免疫估计资源分析了ELF3 - 5与多种免疫细胞浸润之间的关联。随后,选择ELF4并评估其与生物学功能的关联。进行细胞计数试剂盒 - 8(CCK - 8)、集落形成、Transwell、巨噬细胞趋化性和极化分析以验证ELF4的功能。值得注意的是,ELF4的mRNA表达水平在ccRCC中显著上调,而ELF3和ELF5的mRNA表达水平显著下调。临床意义分析显示,ELF4在肿瘤分级、透明细胞A和B亚型以及基因变异中的扩增发生率方面具有较高的临床意义。进一步分析表明,ELF4可能参与多种免疫细胞分化。此外,细胞实验表明,抑制ELF4可下调769 - P和786 - O细胞的增殖、迁移和侵袭。在癌细胞中敲低ELF4也抑制了M2巨噬细胞极化以及对769 - P和786 - O细胞的趋化性。总之,本研究结果表明ELF4在ccRCC中的临床意义,并验证了其在驱动ccRCC细胞增殖、迁移和侵袭以及促进M2巨噬细胞极化和趋化性中的关键作用。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a61f/10433703/bb6b8a10f0e1/ol-26-03-13981-g07.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a61f/10433703/5daee3c324e5/ol-26-03-13981-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a61f/10433703/8b9302780250/ol-26-03-13981-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a61f/10433703/157694cec4dd/ol-26-03-13981-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a61f/10433703/04ed3668f4a8/ol-26-03-13981-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a61f/10433703/d48e1f9068d3/ol-26-03-13981-g04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a61f/10433703/4acb7f9c6f11/ol-26-03-13981-g05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a61f/10433703/74ffd5860fe6/ol-26-03-13981-g06.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a61f/10433703/bb6b8a10f0e1/ol-26-03-13981-g07.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a61f/10433703/5daee3c324e5/ol-26-03-13981-g00.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a61f/10433703/8b9302780250/ol-26-03-13981-g01.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a61f/10433703/157694cec4dd/ol-26-03-13981-g02.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a61f/10433703/04ed3668f4a8/ol-26-03-13981-g03.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a61f/10433703/d48e1f9068d3/ol-26-03-13981-g04.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a61f/10433703/4acb7f9c6f11/ol-26-03-13981-g05.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a61f/10433703/74ffd5860fe6/ol-26-03-13981-g06.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/a61f/10433703/bb6b8a10f0e1/ol-26-03-13981-g07.jpg

相似文献

1
Comprehensive analysis of E47‑like factors and verification of ELF4 in clear cell renal cell carcinoma.透明细胞肾细胞癌中E47样因子的综合分析及ELF4的验证
Oncol Lett. 2023 Jul 27;26(3):395. doi: 10.3892/ol.2023.13981. eCollection 2023 Sep.
2
TRAF2 promotes M2-polarized tumor-associated macrophage infiltration, angiogenesis and cancer progression by inhibiting autophagy in clear cell renal cell carcinoma.TRAF2 通过抑制透明细胞肾细胞癌中的自噬作用促进 M2 极化的肿瘤相关巨噬细胞浸润、血管生成和癌症进展。
J Exp Clin Cancer Res. 2023 Jul 6;42(1):159. doi: 10.1186/s13046-023-02742-w.
3
Expression of gasdermin D in clear cell renal cell carcinoma and its effect on its biological function.Gasdermin D在肾透明细胞癌中的表达及其对其生物学功能的影响。
Front Oncol. 2023 Jul 6;13:1163714. doi: 10.3389/fonc.2023.1163714. eCollection 2023.
4
Downregulation of CLDN7 due to promoter hypermethylation is associated with human clear cell renal cell carcinoma progression and poor prognosis.CLDN7 启动子超甲基化导致其表达下调与人类肾透明细胞癌的进展和不良预后相关。
J Exp Clin Cancer Res. 2018 Nov 14;37(1):276. doi: 10.1186/s13046-018-0924-y.
5
High GTSE1 expression promotes cell proliferation, metastasis and cisplatin resistance in ccRCC and is associated with immune infiltrates and poor prognosis.高GTSE1表达促进ccRCC中的细胞增殖、转移和顺铂耐药,并与免疫浸润和不良预后相关。
Front Genet. 2023 Mar 14;14:996362. doi: 10.3389/fgene.2023.996362. eCollection 2023.
6
The mechanism of long-chain acyl-CoA synthetase 3 in inhibiting cell proliferation, migration, and invasion in clear cell renal cell carcinoma.长链脂酰辅酶A合成酶3在抑制肾透明细胞癌细胞增殖、迁移和侵袭中的作用机制
Am J Cancer Res. 2023 Mar 15;13(3):835-851. eCollection 2023.
7
SPRR3, a novel miR-338-3p target, regulates the malignant progression of clear cell renal cell carcinoma via the PI3K/Akt signaling pathway.SPRR3是一种新的miR-338-3p靶点,通过PI3K/Akt信号通路调节透明细胞肾细胞癌的恶性进展。
Exp Ther Med. 2022 May;23(5):317. doi: 10.3892/etm.2022.11246. Epub 2022 Mar 8.
8
Comprehensive analysis of prognostic value, immune implication and biological function of CPNE1 in clear cell renal cell carcinoma.CPNE1在透明细胞肾细胞癌中的预后价值、免疫意义及生物学功能的综合分析
Front Cell Dev Biol. 2023 Apr 3;11:1157269. doi: 10.3389/fcell.2023.1157269. eCollection 2023.
9
POLD1 as a Prognostic Biomarker Correlated with Cell Proliferation and Immune Infiltration in Clear Cell Renal Cell Carcinoma.POLD1 作为与透明细胞肾细胞癌细胞增殖和免疫浸润相关的预后生物标志物。
Int J Mol Sci. 2023 Apr 6;24(7):6849. doi: 10.3390/ijms24076849.
10
Identification of the Expression and Clinical Significance of E2F Family in Clear Cell Renal Cell Carcinoma.E2F家族在肾透明细胞癌中的表达及临床意义的鉴定
Int J Gen Med. 2022 Feb 5;15:1193-1212. doi: 10.2147/IJGM.S349723. eCollection 2022.

引用本文的文献

1
ETS-1 in tumor immunology: implications for novel anti-cancer strategies.肿瘤免疫学中的ETS-1:对新型抗癌策略的启示
Front Immunol. 2025 Mar 20;16:1526368. doi: 10.3389/fimmu.2025.1526368. eCollection 2025.

本文引用的文献

1
c-Myc-induced long noncoding RNA MIRE cooperates with hnRNPK to stabilize ELF2 mRNA and promotes clear cell renal cell carcinogenesis.c-Myc 诱导的长非编码 RNA MIRE 与 hnRNPK 合作稳定 ELF2 mRNA 并促进透明细胞肾细胞癌发生。
Cancer Gene Ther. 2023 Sep;30(9):1215-1226. doi: 10.1038/s41417-023-00631-0. Epub 2023 May 29.
2
ELF3 promotes gemcitabine resistance through PKMYT1/CDK1 signaling pathway in gallbladder cancer.ELF3 通过 PKMYT1/CDK1 信号通路促进胆囊癌对吉西他滨的耐药性。
Cell Oncol (Dordr). 2023 Aug;46(4):1085-1095. doi: 10.1007/s13402-023-00799-5. Epub 2023 Mar 29.
3
FGF19-mediated ELF4 overexpression promotes colorectal cancer metastasis through transactivating FGFR4 and SRC.
成纤维细胞生长因子 19(FGF19)介导的 E74 样因子 4(ELF4)过表达通过反式激活成纤维细胞生长因子受体 4(FGFR4)和 SRC 促进结直肠癌转移。
Theranostics. 2023 Feb 22;13(4):1401-1418. doi: 10.7150/thno.82269. eCollection 2023.
4
Changes in DNA methylation profile in liver tissue during progression of HCV-induced fibrosis to hepatocellular carcinoma.丙型肝炎病毒(HCV)诱导的肝纤维化进展为肝细胞癌过程中肝脏组织DNA甲基化谱的变化。
Vavilovskii Zhurnal Genet Selektsii. 2023 Mar;27(1):72-82. doi: 10.18699/VJGB-23-10.
5
Exosomal circZNF451 restrains anti-PD1 treatment in lung adenocarcinoma via polarizing macrophages by complexing with TRIM56 and FXR1.外泌体环状 RNA ZNF451 通过与 TRIM56 和 FXR1 复合物来极化巨噬细胞,从而抑制肺腺癌的抗 PD-1 治疗。
J Exp Clin Cancer Res. 2022 Oct 8;41(1):295. doi: 10.1186/s13046-022-02505-z.
6
..
Mol Pharmacol. 2022 Sep 27;102(6):MOLPHARM-AR-2022-000525. doi: 10.1124/molpharm.122.000525.
7
Identification of Prognostic Factors in Cholangiocarcinoma Based on Integrated ceRNA Network Analysis.基于整合 ceRNA 网络分析的胆管癌预后因素鉴定。
Comput Math Methods Med. 2022 Sep 15;2022:7102736. doi: 10.1155/2022/7102736. eCollection 2022.
8
ELF4 is a critical component of a miRNA-transcription factor network and is a bridge regulator of glioblastoma receptor signaling and lipid dynamics.ELF4 是 miRNA-转录因子网络的关键组成部分,也是神经胶质瘤受体信号和脂质动态的桥梁调节因子。
Neuro Oncol. 2023 Mar 14;25(3):459-470. doi: 10.1093/neuonc/noac179.
9
Automatic Integration of Clinical and Genetic Data Using cBioPortal.利用 cBioPortal 实现临床与基因数据的自动整合。
Stud Health Technol Inform. 2022 Jun 6;290:799-803. doi: 10.3233/SHTI220189.
10
European Association of Urology Guidelines on Renal Cell Carcinoma: The 2022 Update.欧洲泌尿外科学会肾癌指南:2022 年更新版。
Eur Urol. 2022 Oct;82(4):399-410. doi: 10.1016/j.eururo.2022.03.006. Epub 2022 Mar 26.